# Boehringer Ingelheim adds filling line to Shanghai biopharma facility

Boehringer Ingelheim has added a new filling line to its OASIS facility in Shanghai, China, expanding its contract drug manufacturing capabilities for biopharmaceuticals. The expansion includes an isolator-based fill & finish line for aseptic filling of liquids in vials.

- Type: Expansion
- Announced: 2018-07-06
- Where: Shanghai, China
- Status: completed
- Products: biopharmaceuticals
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Boehringer Ingelheim](https://endata.com/companies/25171.md)

## Sources

- [pharmaceutical-technology.com](https://www.pharmaceutical-technology.com/news/boehringer-expands-drug-manufacturing-china/), 2018-07-05: "I believe that our customers will benefit from this investment by receiving high quality drug substance and drug product from one source as a convenient pathway to deliver biopharmaceuticals to our customers and, in the end, to patients."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.